Global petrol prices: Fuel prices (petrol and diesel) have taken surged across the globe as the war in West Asia, which started on 29 February after the United States and…
Author: Admin
Sebi flags rise in fraudulent trading apps siphoning investor money
Securities and Exchange Board of India (Sebi) chairman Tuhin Kanta Pandey warned about a surge in apps that siphon off investor money, as the regulator partnered with Google Play to…
SEBI fills WTM vacancy with KV Ramana Murty
The government has filled a key vacancy on the SEBI board with the appointment of Kompella Venkata Ramana Murty as whole-time member (WTM), restoring the regulator’s full strength and setting…
Wall Street jumps on prospects of de-escalation in Middle East war
US stock indices jumped on Wednesday on prospects of de-escalation in the Middle East conflict. At the opening bell, the Dow Jones Industrial Average rose 190.2 points, or 0.41%, to…
SEBI proposes IT Resilience Index to enhance market infrastructure oversight
SEBI on Wednesday proposed a framework to introduce an IT Resilience Index (ITRI) for Market Infrastructure Institutions (MIIs), to strengthen oversight of critical technology systems in the securities market. In…
Gold surges 4% as ceasefire hopes drive India’s second straight ally
Markets closed higher for the second consecutive session on Wednesday, while emerged as a standout performer, surging nearly 4 per cent on to $4,556 per ounce, as diplomatic signals between…
Weak sentiment keeps Kashmir gold demand muted despite dip in prices
Despite a recent dip in gold prices ahead of the wedding season, demand for the precious metal remains subdued in Kashmir, reflecting weak consumer sentiment and financial stress among households.…
Rocketlane raises $60mn Series C round, led by US-based PE firm Insight Partners
Rocketlane, an artificial intelligence(AI)-powered professional services automation (PSA) platform, has raised $60 million in its Series C funding round led by US-based private equity firm Insight Partners. The Chennai-based startup…
Novo Nordisk sues Dr. Reddy’s over Ozempic trademark
MUMBAI/NEW DELHI: As semaglutide, the drug behind weight-loss drug Ozempic, goes off-patent in India and cheaper copies flood the market, Novo Nordisk has moved to defend its flagship brand, kicking…
Ceigall India stock ends 4% higher after securing ₹1,369 crore solar PPA projects; still down 31% from IPO price
Shares of closed Wednesday’s session, March 25, higher by 4% at ₹275 apiece, as investor sentiment improved after the company executed two long-term Power Purchase Agreements (PPAs). In a regulatory…